There must be a way out of here: identifying a safe and efficient combination of promoter, transgene, and vector backbone for gene therapy of neurological disease

Mol Ther. 2014 Feb;22(2):246-247. doi: 10.1038/mt.2013.297.

¹ Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA. Electronic address: pedrol@umich.edu.
² Department of Neurosurgery and Department of Cell and Developmental Biology, Cancer Center, Program in Cancer Biology, Immunology, and Neuroscience, University of Michigan Medical School, Ann Arbor, Michigan, USA.

No abstract available

Publication types